These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7031320)

  • 21. [Reduction of hyperfibrinemia in the nephrotic syndrome using defibrase].
    Salvadori JM; Follana R; Olmer M
    J Urol Nephrol (Paris); 1975 Sep; 81(9):691-6. PubMed ID: 1214313
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical pharmacology of the hemocoagulase isolated from Bothrops jararaca venom].
    Pupita F; Di Placido V; Zini R; Pupita P
    Clin Ter; 1982 Jun; 101(6):629-38. PubMed ID: 6751665
    [No Abstract]   [Full Text] [Related]  

  • 23. [The use of reptilase for electrophoresis of heparinized plasma (author's transl)].
    Heimann D; Wolf V; Keller H
    J Clin Chem Clin Biochem; 1979 Jun; 17(6):369-72. PubMed ID: 458385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of herpes zoster with hemocoagulase (Bothrops Jararaca venom)].
    De Candia O; Baghiris D
    Clin Ter; 1979 Jun; 89(6):589-93. PubMed ID: 397028
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 26. [Defibrination-therapy using a thrombin-like snake venom enzyme (Defibrase) Blood-coagulation physiological studies and clinical experiences].
    Martin M; Engelken HJ; Tambert F; Martin U; Hirdes E; Auel H
    Vasa Suppl; 1976; 5():1-39. PubMed ID: 1070197
    [No Abstract]   [Full Text] [Related]  

  • 27. Haemocoagulase obtained from snake venom in the management haemoptysis due to pulmonary tuberculosis.
    Khanna BK
    Indian J Chest Dis Allied Sci; 1983; 25(4):259-61. PubMed ID: 6384035
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinico-morphologic characteristics of experimental autoimmune glomerulonephritis during the use of prednisolone].
    Bykovskaia KN
    Arkh Patol; 1969; 31(6):32-7. PubMed ID: 5358924
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative evaluation of the effectiveness of prednisolone and indotsid in the treatment of experimental autoimmune glomerulonephritis].
    Bykovskaia KN; Megrelishvili RI
    Patol Fiziol Eksp Ter; 1973; 17(2):14-20. PubMed ID: 4710416
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Klobusitzky's hemocoagulasis in the treatment of hemorrhage in pediatrics].
    Biscatti G; Bruschelli M; Bianchi E
    Minerva Pediatr; 1975 Mar; 27(7):449-52. PubMed ID: 1143228
    [No Abstract]   [Full Text] [Related]  

  • 32. [Platelet antiaggregation and anticoagulant drugs in the treatment of proliferative glomerulonephritis in children].
    Genova R; Barbieri U; Cocconcelli P; Boselli F
    Minerva Pediatr; 1979 Jan; 31(2):171-85. PubMed ID: 460074
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypothesis: immune complex glomerulonephritis and auto-immunity (author's transl)].
    Fournié GJ; Lulé J; Gayral-Ta Minh M; Mignon-Conté MA; Pourrat JP; Conté JJ
    Nephrologie; 1981; 2(3):107-8. PubMed ID: 6457998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinico-pharmacological observations of batroxobin (Defibrase) administered to normal human adults (author's transl)].
    Fukutake K; Fujimaki M; Nagasawa H; Kato M
    Nihon Ketsueki Gakkai Zasshi; 1981 Nov; 44(6):1178-94. PubMed ID: 7036639
    [No Abstract]   [Full Text] [Related]  

  • 35. [The anti-edematous effect of an association of proteolytic enzymes, flavonoids, sterolic heteroside of Ruscus aculeatus and ascorbic acid (author's transl)].
    Tarayre JP; Lauressergues H
    Ann Pharm Fr; 1979; 37(5-6):191-8. PubMed ID: 396842
    [No Abstract]   [Full Text] [Related]  

  • 36. Strain specific responses of inbred rats on the severity of experimental autoimmune glomerulonephritis.
    Sado Y; Naito I; Akita M; Okigaki T
    J Clin Lab Immunol; 1986 Apr; 19(4):193-9. PubMed ID: 3522918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defibrinogenation treatment in patients suffering from severe intermittent claudication - a controlled study.
    Martin M; Hirdes E; Auel H
    Thromb Res; 1976 Jul; 9(1):47-57. PubMed ID: 785691
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of vitamin D3 and cyclosporin A on HgCl2-induced autoimmunity in brown Norway rats.
    Vendeville B; Baran D; Gascon-Barré M
    Nephrol Dial Transplant; 1995 Nov; 10(11):2020-6. PubMed ID: 8643162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of indometacin for treating diffuse glomerulonephritis under experimental and clinical conditions.
    Vihert AM; Glezer GA; Megrelishvili RI; Ryff IM
    Arzneimittelforschung; 1973 Jul; 23(7):991-6. PubMed ID: 4800460
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel immunosuppressant FTY720 ameliorates proteinuria and alterations of intrarenal adrenomedullin in rats with autoimmune glomerulonephritis.
    Shi Y; Yoshihara F; Nakahama H; Ichimaru N; Yazawa K; Sada M; Goto R; Kawano Y; Moriyama T; Takahara S; Okuyama A; Kangawa K
    Regul Pept; 2005 Apr; 127(1-3):233-8. PubMed ID: 15680492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.